Dr. Reddy's and Alvotech partner to develop and commercialize Biosimilar to Keytruda
By Aman Shukla Published on June 5, 2025, 08:41 IST
Dr. Reddy's Laboratories Ltd., a leading Indian pharmaceutical company, has entered into a strategic collaboration with Alvotech, a global biotech firm specializing in biosimilar medicines. The partnership aims to co-develop, manufacture, and commercialize a biosimilar version of Keytruda® (pembrolizumab), a groundbreaking cancer treatment used for multiple cancer types worldwide.
Keytruda® is a highly successful immunotherapy drug, with global sales reaching an impressive US$29.5 billion in 2024. By combining their expertise, Dr. Reddy's and Alvotech plan to accelerate the biosimilar's development timeline and expand its availability across international markets.
Under the agreement, both companies will share development costs and responsibilities, ensuring efficient manufacturing and distribution. Each partner retains the right to commercialize the biosimilar globally, with certain exceptions, maximizing reach and impact.
'We are very pleased to enter into this collaboration for pembrolizumab with Dr. Reddy's. This agreement demonstrates Alvotech's ability to leverage its dedicated R&D and manufacturing platform for biosimilars, accelerating the expansion of our pipeline by pursuing growing global markets. It further enables us to increase the availability of cost-effective, critical biologic medications to patients world-wide,' said Róbert Wessman, chairman and CEO of Alvotech.
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
34 minutes ago
- Associated Press
How AirCarbon Is Turning Greenhouse Gases Into Ocean-Friendly Plastic Alternatives
As World Oceans Day approaches on June 8, 2025, we are reminded of the urgent need to protect our blue planet. This year's theme, 'Sustainable Fishing Means More,' highlights the growing demand for innovation to preserve marine ecosystems and fight climate change. Among the most promising breakthroughs in ocean-inspired sustainability is AirCarbon®, a regenerative, carbon-negative material created by Newlight Technologies. The Science: From Microbes to Materials AirCarbon® was born from an extraordinary scientific discovery. While researching oil spills, scientists observed oceanic microorganisms consuming methane, a potent greenhouse gas, and naturally producing Polyhydroxybutyrate (PHB) within their cells. This polymer mimics the characteristics of polypropylene, a common plastic, but with a critical difference: PHB is biodegradable and renewable. Newlight Technologies scaled this biological process into a commercially viable innovation. Using air and greenhouse gases dissolved in water, they produce AirCarbon®, a plastic alternative now used in cutlery, straws, eyewear, leather substitutes, and more. With over 50 patents and more than a decade of R&D, AirCarbon® offers an elegant, market-driven solution to reduce plastic waste and climate impact. AirCarbon® isn't just a promising innovation—it's already making waves across industries. Companies like Nike and H&M have partnered with Newlight Technologies to incorporate AirCarbon® into sustainable fashion collections, while Shake Shack, Target, and Ben & Jerry's have piloted its use in foodware to reduce single-use plastic waste. In hospitality, Marriott International has adopted AirCarbon® utensils in select locations, and in the automotive space, Sumitomo Chemical is exploring its potential for carbon-negative materials. These partnerships demonstrate AirCarbon's versatility and growing role in helping brands meet their environmental commitments. Scaling Sustainability In recent developments, Newlight announced plans for a $1.1 billion manufacturing facility in Manitoba, Canada, further expanding their capacity to meet the demand for sustainable materials. This follows a $125 million equity round led by GenZero, reinforcing the company's path toward industrial-scale impact. As governments and corporations seek actionable ways to meet ESG targets, AirCarbon® stands out as a proven alternative—both technologically and environmentally sound. Featured on the RENEWables Podcast To explore the deeper implications of this breakthrough, Mark Herrema, Co-Founder & CEO of Newlight Technologies, joined the RENEWables podcast. In Episode #36, Herrema shares the origin story of AirCarbon®, the challenges of scaling biological innovation, and how circular economy principles can guide the future of materials. 'AirCarbon is not just about replacing plastic—it's about capturing carbon, restoring balance, and rethinking how we interact with the natural world.' — Mark Herrema Don't miss this powerful to the full episode of RENEWables featuring Mark Herrema here: RENEWables #36: AirCarbon ®Share the episode with your network to help elevate solutions that matter this World Oceans Day. Visit 3BL Media to see more multimedia and stories from BioStar Renewables
Yahoo
36 minutes ago
- Yahoo
Live Laser-based Training and Simulation Platforms Research Report 2025-2030: Growing Emphasis on Realism and Combat Readiness Spurs Use of Precision Laser Engagement Systems in Field Training
The global Live Laser-based Training and Simulation Platforms market, valued at $680.1M in 2024, is projected to reach $902.0M by 2030, growing at a 4.8% CAGR. This growth reflects rising demand for advanced simulation in defense and public safety. The market report offers insights into trends and drivers, including technological innovations in sensors and data analytics, driving precision and realism in training. As AR, AI, and GPS integrations enhance training environments, the report analyzes regional opportunities and challenges, with key growth seen in the U.S. and China. Access comprehensive market data, competitive analysis, and insights into global tariff impacts. Live Laser-based Training and Simulation Platforms Market Dublin, June 06, 2025 (GLOBE NEWSWIRE) -- The "Live Laser-based Training and Simulation Platforms - Global Strategic Business Report" has been added to global market for Live Laser-based Training and Simulation Platforms was valued at US$680.1 Million in 2024 and is projected to reach US$902.0 Million by 2030, growing at a CAGR of 4.8% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. Live laser-based training and simulation platforms have become integral to modern defense and public safety readiness programs. These systems use eye-safe laser emitters, detectors, and GPS-enabled tracking to create highly realistic, real-time training environments without the logistical burden or safety risks of live ammunition. Known as MILES (Multiple Integrated Laser Engagement System) or similar frameworks, these platforms replicate battlefield or tactical conditions by simulating weapon effects, target acquisition, hits, and kills in both open and urban terrains. As armed forces and law enforcement agencies seek to improve situational preparedness, judgment under pressure, and engagement accuracy, these systems provide immersive and scalable training Is Driving Global Growth in the Live Laser-Based Training and Simulation Market?The growth in the live laser-based training and simulation platforms market is driven by heightened defense preparedness needs, innovation in sensor-integrated simulation systems, and rising government investments in modern combat training. A key driver is the global shift toward cost-effective, scalable, and safer alternatives to live ammunition training. Laser-based systems enable repeatable, high-frequency exercises with detailed post-exercise debriefing - essential for building operational readiness without the associated logistics or safety burden of live increasing complexity of asymmetric and urban warfare is also encouraging the use of adaptable, modular, and location-aware simulation systems. Technological convergence with AR, GPS, and AI is expanding capabilities and performance metrics, turning training into a data-rich environment for strategic insight. Government spending on soldier modernization programs, training base upgrades, and public safety initiatives - particularly in the U.S., Europe, Middle East, and Asia-Pacific - is ensuring sustained growth. As interagency training, multinational coordination, and smart defense become the new norm, laser-based simulation platforms are positioned to become a central component of 21st-century tactical training Is Technology Enhancing Precision, Immersion, and Integration in Live Training?Modern laser-based training systems are being revolutionized by advances in sensors, wearables, wireless communication, and data analytics. New-generation systems incorporate body-worn sensors, helmet-mounted receivers, GPS trackers, and inertial measurement units (IMUs) to capture detailed combat movement and engagement outcomes. Laser systems are now more accurate and weather-resistant, with enhanced signal fidelity to support engagements across longer distances and multi-weapon with augmented reality (AR) visors, real-time location tracking, and AI-based scoring algorithms is providing trainees and commanders with instant performance feedback. Cloud-based platforms allow for centralized data aggregation, enabling commanders to evaluate mission flow, decision-making patterns, and tactical alignment. Some systems also feature smart vests and weapon retrofits to simulate recoil, injury effects, and stress-based scenarios, enhancing realism without compromising safety. These advancements are transforming laser-based simulation from a basic hit-detection system into a full-spectrum tactical training Adoption Trends Are Shaping Demand Across Defense and Public Security Sectors?Defense ministries around the world are investing in laser-based simulation systems to modernize training infrastructure amid rising geopolitical tensions and hybrid warfare scenarios. Special forces, infantry, and armored units are using these systems for live-fire substitute drills, room-clearing simulations, and hostage rescue training. Urban operations training centers, mock villages, and modular combat zones are being equipped with laser simulation networks to replicate combat-in-built-up-areas (CIBUA) conditions. Multinational NATO and UN exercises are also leveraging standardized laser training protocols to ensure cross-border coordination and counter-terrorism units, and corrections departments are increasingly adopting these platforms for active shooter response, de-escalation drills, and riot control simulations. With an emphasis on force protection and civilian safety, these systems help train law enforcement personnel in threat discrimination and rules-of-engagement protocols under simulated real-world pressure. Commercial adoption is also rising in private security training and defense contractor programs, particularly in regions investing heavily in internal defense ScopeReport Features: Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030. In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa. Company Profiles: Coverage of players such as Airbus S.A.S., BAE Systems, CAE Inc., Cobham Limited, Cubic Corporation and more. Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments. Key Insights: Market Growth: Understand the significant growth trajectory of the Hardware Component segment, which is expected to reach US$591.6 Million by 2030 with a CAGR of a 5.7%. The Software Component segment is also set to grow at 3.2% CAGR over the analysis period. Regional Analysis: Gain insights into the U.S. market, valued at $185.3 Million in 2024, and China, forecasted to grow at an impressive 8.9% CAGR to reach $190.6 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific. Segments Component (Hardware, Software) Application (Flight Simulation, Battlefield Simulation, Defense, Medic Training, Vehicle Simulation, Airborne Simulation, Navalsimulation, Ground Simulation, Other Applications) End-Use (Defense Security, Civil Aviation, Education, E-Learning, Game Based Learning, Other End-Uses) Tariff Impact Analysis: Key Insights for 2025What's Included in This Edition: Tariff-adjusted market forecasts by region and segment Analysis of cost and supply chain implications by sourcing and trade exposure Strategic insights into geographic shifts Buyers receive a free July 2025 update with: Finalized tariff impacts and new trade agreement effects Updated projections reflecting global sourcing and cost shifts Expanded country-specific coverage across the industry Key Attributes: Report Attribute Details No. of Pages 399 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $680.1 Million Forecasted Market Value (USD) by 2030 $902 Million Compound Annual Growth Rate 4.8% Regions Covered Global MARKET OVERVIEW Influencer Market Insights World Market Trajectories Tariff Impact on Global Supply Chain Patterns Live Laser-based Training and Simulation Platforms Global Key Competitors Percentage Market Share in 2025 (E) Competitive Market Presence Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E) MARKET TRENDS & DRIVERS Modernization of Military Training Programs Drives Adoption of Live Laser-Based Simulation Platforms Growing Emphasis on Realism and Combat Readiness Spurs Use of Precision Laser Engagement Systems in Field Training Expansion of Urban Warfare and Asymmetric Threat Scenarios Increases Demand for Laser-Based Tactical Training Tools Push for Cost-Effective, Non-Lethal Force Replication Strengthens Business Case for Live Laser Engagement Solutions Integration of GPS, IR, and Laser Technology Enhances Real-Time Soldier Tracking and Engagement Accuracy Increased Use of Integrated After-Action Review (AAR) Systems Enhances Tactical Feedback and Learning Outcomes Growth in Joint Training Exercises Among Allied Forces Fuels Demand for Interoperable and Scalable Simulation Platforms Military Investment in Network-Centric Training Environments Supports Live Laser Integration With Virtual Platforms Rising Focus on Combat Simulation for Peacekeeping and Counterterrorism Training Expands Laser System Deployments Procurement of Portable and Deployable Simulation Kits Boosts Adoption in Remote and Hostile Environments FOCUS ON SELECT PLAYERS Airbus S.A.S. BAE Systems CAE Inc. Cobham Limited Cubic Corporation Elbit Systems Ltd. FlightSafety International General Dynamics Corporation Inter-Coastal Electronics Inc. Kratos Defense & Security Solutions, Inc. L3Harris Technologies, Inc. Leonardo S.p.A. Lockheed Martin Corporation Northrop Grumman Corporation Raytheon Technologies Corporation Rheinmetall AG RUAG Group Saab AB Thales Group ZelTech For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Live Laser-based Training and Simulation Platforms Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Business Wire
an hour ago
- Business Wire
HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors
MINNEAPOLIS--(BUSINESS WIRE)-- HistoSonics, Inc., the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the completion of patient enrollment in its pivotal #HOPE4KIDNEY trial. This prospective, multi-center, single-arm trial is designed to evaluate the safety and effectiveness of the Edison System in destroying kidney tissue by treating primary solid kidney tumors. 'Our vision is for the Edison System to become a foundational, non-invasive solution across a wide range of clinical applications,' said Mike Blue, President and CEO, HistoSonics. The trial enrolled patients with a single, non-metastatic solid kidney mass ≤3 cm, confirmed by imaging and biopsy. Subjects will be followed for five years post-procedure, with evaluations at multiple time points, including 14-day, 30-day, 90-day, 180-day, and annual assessments. The Edison System remains in investigational use for kidney applications and is not yet FDA-approved for this indication. Data from the #HOPE4KIDNEY trial is expected to support a future submission for regulatory clearance to expand the use of histotripsy to treat kidney tissue/tumors. The Edison System is the first and only platform to use histotripsy, a non-thermal, non-invasive focused ultrasound technology, to mechanically liquefy tumors without surgery, radiation, or systemic therapies. Unlike invasive surgical approaches, histotripsy does not require incisions and enables real-time imaging and treatment monitoring, allowing physicians to target and control tissue destruction while sparing surrounding structures. 'Our vision is for the Edison System to become a foundational, non-invasive solution across a wide range of clinical applications,' said Mike Blue, President and CEO, HistoSonics. 'Completing enrollment in our pivotal kidney tumor trial represents a significant milestone toward that goal and reinforces our confidence in expanding histotripsy into additional tumor types and indications. This achievement reflects the dedication of our team and clinical partners and brings us closer to transforming the treatment of solid tumors without the need for surgery.' Dr. William C. Huang, MD FACS, Professor and Vice Chair of Urology at the NYU Grossman School of Medicine serves as a principal investigator at the NYU Langone Medical Center, the top enrolling site in the trial. Dr. Huang commented, 'Histotripsy offers a novel, completely non-invasive treatment paradigm for kidney tumors that precisely images and treats tumors while preserving surrounding critical structures thereby minimizing the morbidity associated with traditional surgical and thermal ablative techniques.' Dr. Michael McDonald, Assistant Professor of Urology at the University of Central Florida College of Medicine and Urologic Surgeon at AdventHealth at Celebration Florida, serves as a principal investigator for one of the participating sites in the trial. Dr. McDonald commented, 'HistoSonics represents a paradigm shift proving that the most profound treatments for both benign and malignant diseases need not be the most invasive. The ability to precisely target and destroy tumors without scalpel or scar is the next step in the evolution of non-surgical intervention.' The Edison System has not been evaluated for the treatment of any specific disease, including, but not limited to, cancer or evaluated any specific cancer outcomes (such as local tumour progression, 5-year survival or overall survival). United States Intended Use Statement: The Edison System is intended for the non-invasive mechanical destruction of liver tumors, including the partial or complete destruction of unresectable liver tumors via histotripsy. The FDA has not evaluated the Edison System for the treatment of any disease including, but not limited to, cancer or evaluated any specific cancer outcomes (such as local tumor progression, 5-year survival or overall survival). The System should only be used by physicians who have completed training performed by HistoSonics, and its use guided by the clinical judgment of an appropriately trained physician. Refer to the device Instructions for Use for a complete list of warnings, precautions, and a summary of clinical trial results, including reported adverse events. About HistoSonics HistoSonics is a privately held medical device company developing a non-invasive platform and proprietary sonic beam therapy utilizing the science of histotripsy, a novel mechanism of action that uses focused ultrasound to mechanically destroy and liquify unwanted tissue and tumors. The company is currently focused on commercializing their Edison System in the US and select global markets for liver treatment while expanding histotripsy applications into other organs like kidney, pancreas, prostate, and others. HistoSonics has offices in Ann Arbor, Michigan and Minneapolis, MN. For more information on the Edison Histotripsy System please visit: For patient-related information please visit:
